Trial · NCT07176078
Evaluating the Added Benefit of Osteopathic Care to a Flexi-FODMAP Diet in Fibromyalgia Patients With Irritable Bowel Syndrome
Dietary modifications are often recommended as first-line treatment for irritable bowel syndrome, with the FODMAP diet being the most effective intervention to
- Status
- Recruiting
- Sponsor
- Universitair Ziekenhuis Brussel
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 96 participants (planned)
- Start
- Jan 1, 2026
- Primary completion
- December 2026
- Conditions
- Irritable Bowel Syndrome (IBS), Fibromyalgia (FM)
Summary
Dietary modifications are often recommended as first-line treatment for irritable bowel syndrome, with the FODMAP diet being the most effective intervention to improve global gastrointestinal symptoms. Due to the heterogeneity of symptoms, patients often seek complementary or alternative therapies. This randomized clinical trial aims to determine whether osteopathic care provides additional improvement in gastrointestinal symptoms compared to sham osteopathic care, when both are combined with a flexible FODMAP diet. The trial will also assess the safety and tolerability of osteopathic care.
Interventions
- Osteopathic care Other
- Sham Osteopathic care Other
- Flexi-FODMAP Diet Behavioral
Locations
1 country: Belgium.
| Facility | City | Country |
|---|---|---|
| Vrije Universiteit Brussel | Brussels, Brussels Capital | Belgium |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.